Molecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patients

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Journal	Translational Cancer Research
DOIs	https://doi.org/10.21037/tcr.2017.03.22
Publication status	Published - 1 Mar 2017

Research Beacons, Institutes and Platforms

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{bce74d415ea542e0b7a7d083e06b6086,

title = "Molecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patients",

author = "Xiaomin Niu and Sandra Perdomo and Fiona Blackhall",

year = "2017",

month = mar,

day = "1",

doi = "10.21037/tcr.2017.03.22",

language = "English",

journal = "Translational Cancer Research",

issn = "2218-676X",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Molecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patients

AU - Niu, Xiaomin

AU - Perdomo, Sandra

AU - Blackhall, Fiona

PY - 2017/3/1

Y1 - 2017/3/1

UR - https://www.scopus.com/pages/publications/85016767621

U2 - 10.21037/tcr.2017.03.22

DO - 10.21037/tcr.2017.03.22

M3 - Editorial

SN - 2218-676X

JO - Translational Cancer Research

JF - Translational Cancer Research

ER -